Use of phosphate-binding agents is associated with a lower risk of mortalityJorge B. Cannata‐Andía, Carmine Zoccali, Markus Ketteler et al.|Kidney International|2013Cited by 158
COSMOS: the dialysis scenario of CKD–MBD in EuropeJosé Luis Fernández Martín, Jorge B. Cannata‐Andía, Juan Jesús Carrero et al.|Nephrology Dialysis Transplantation|2012Cited by 92
Influence of Body Mass Index on the Association of Weight Changes with Mortality in Hemodialysis PatientsIván Cabezas‐Rodríguez, Jorge B. Cannata‐Andía, Juan Jesús Carrero et al.|Clinical Journal of the American Society of Nephrology|2013Cited by 63
Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS studyJosé Luis Fernández Martín, S. Croft, Adriana Dusso et al.|Nephrology Dialysis Transplantation|2018Cited by 33
Determination of high molecular mass Al species in serum and spent CAPD fluids of dialysis patients combining SEC and anion-exchange FPLC with ETAAS detectionBlaž Kralj, Radmila Milačić, Janez Ščančar et al.|Journal of Analytical Atomic Spectrometry|2004Cited by 20